This new drug, the company argues, shouldn't cause heart valve problems.

FORBES: Magazine Article

But he also said that this six-month analysis simply doesn't assuage his fears of heart valve problems.

FORBES: Magazine Article

It is entirely possible for there to be some numeric trend toward an increase in heart valve problems that the safety panel didn't think was worth stopping the trial.

FORBES: Magazine Article